Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer

Japanese Journal of Clinical Oncology

Volumn 34, Issue 12, 2004, Pages 740-746

  Suzuki, Toshiyuki ^a   Sadahiro, Sotaro ^a   Fukasawa, Maki ^a   Ishikawa, Kenji ^a   Kamijo, Akemi ^a   Yasuda, Seiei ^a   Makuuchi, Hiroyasu ^a   Ohizumi, Yukio ^a   Murayama, Chieko ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; p21; p53; Radiation sensitivity; Rectal cancer

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KI 67 ANTIGEN; TUMOR MARKER;

APOPTOSIS; ARTICLE; BIOPSY; CANCER STAGING; CONTROLLED STUDY; ELECTRON BEAM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; RECTUM CANCER; TUMOR REGRESSION; ADENOCARCINOMA; ADULT; AGED; FEMALE; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREOPERATIVE CARE; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECTUM; RECTUM TUMOR; REMISSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL CYCLE PROTEINS; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE FRACTIONATION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14544276517     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh140     Document Type: Article

References (27)

1. Pilipshen SJ, Heilweil M, Quan SH, Stemberg SS, Enker WE. Pattern of pelvic recurrence following definitive resection of rectal cancer. Cancer 1984;53:1354-62.
2. Neville R, Fielding LP, Amendola C. Local tumor recurrence after curative resection for rectal cancer. A ten-hospital review. Dis Colon Rectum 1987;30:12-7.
3. CCCG. Adjuvant radiotherapy for rectal cancer, a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;20:1291-304.
4. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer. N Eng J Med 1997;336:980-7.
5. Holm T, Singnomklao T, Rutqvist LE, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 1996;78:968-76.
6. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
7. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335-46.
8. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
9. Marijnen CA, Kapiteijn E, van de Velde CJ, Martijin H, Steup WH, Wiggers T, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002;20:817-25.
10. Sadahiro S, Suzuki T, Ishikawa K, Yasuda S, Tajima T, Makuuchi H, et al. Intraoperative radiation therapy for curatively resected rectal cancer. Dis Colon Rectum 2001;44:1689-95.
11. Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619-27.
12. Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 1999;51:153-60.
13. Willett CG, Warland G, Coen J, Shellito PC, Compton CC. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995;32:57-61.
14. Willett CG, Warland G, Hagan MP, Daly WJ, Coen J, Shellito PC, et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417-24.
15. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 1993;362:847-52.
16. Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 1994;54:5824-30.
17. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma. Tokyo: Kanehara 1997.
18. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M. Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal correlation. Clinicopathologic correlations. Cancer 1994;73:2680-6.
19. Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Cleary KR Dubrow RA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-9.
20. Sadahiro S, Suzuki T, Ishikawa K, Yasuda S, Tajima T, Makuuchi H, et al. Intraoperative radiation therapy for curatively resected rectal cancer. Dis Colon Rectum 2001;44:1689-95.
21. Sadahiro S, Suzuki T, Ishikawa K, Mukai M, Tokunaga N, Tajima T, et al. Development of an irradiation method of intraoperative radiation therapy for curatively resected rectal cancer. Int J Clin Oncol 1999;4:210-4.
22. Suzuki K, Gunderson LL, Devine RM, Weaver AL, Dozois RR, Ilstrup DM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995;15:939-52.
23. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990;9:1595-602.
24. Namba H, Hara T, Tukazaki T, Migita K, Ishikawa N, Ito K, et al. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res 1995;55:2075-80.
25. Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 1995;11:199-210.
26. Fu C-G, Tominaga O, Nagawa H, Nitta ME, Masaki T, Ishimaru G, et al. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 1998;41:68-74.
27. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396.